Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2010
[Long-term survival of a breast cancer patient with liver metastasis treated with trastuzumab and Paclitaxel]Yohei Ota, Takashi Ishikawa, Akimitsu Yamada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Case of cy1 Advanced Gastric Cancer That Achieved CR after Chemotherapy Via an Enterostomy]Hidetaka A Ono, Yohei Ota, Hirokazu Suwa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[Investigation of Preoperative Chemotherapy Using Enterostomy for Advanced Gastric Cancer with Stenosis]Hidetaka A Ono, Yohei Ota, Hirokazu Suwa, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 2, 2020
Prophylactic drain management after pancreaticoduodenectomy without focusing on the drain fluid amylase level: A prospective validation study regarding criteria for early drain removal that do not include the drain fluid amylase levelKoichi Taniguchi, Ryusei Matsuyama, Yasuhiro Yabushita, et al.Clinical Journal of Gastroenterology|December 10, 2013
Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a caseYohei Ota, Ryusei Matsuyama, Koichi Taniguchi, et al.In Vivo (Athens, Greece)|April 28, 2019
A Simple and Easily Reproducible Model of Reversible Obstructive Jaundice in RatsSeigo Hiratani, Ryutaro Mori, Yohei Ota, et al.World Journal of Surgery|December 12, 2018
Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar CholangiocarcinomaRyusei Matsuyama, Daisuke Morioka, Ryutaro Mori, et al.Cancer Chemotherapy and Pharmacology|March 30, 2018
Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility studyRyusei Matsuyama, Daisuke Morioka, Ryutaro Mori, et al.Annals of Surgical Oncology|July 9, 2016
Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and ReconstructionRyusei Matsuyama, Ryutaro Mori, Yohei Ota, et al.Annals of Surgical Oncology|January 7, 2022
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar CholangiocarcinomaRyusei Matsuyama, Ryutaro Mori, Yohei Ota, et al.Pageof 2